baber/WOPTO huggingface dataset:
Patent NZ-579890-A (NZ)
Title: 4'-o-substituted isoindoline derivatives and compositions comprising and methods of using the same
Inventor: RUCHELMAN ALEXANDER L
IPC: C07D403/04
Filed: 2008-03-19
Abstract: Disclosed are 4'-O-substituted isoindoline compounds of structural formula shown herein, and pharmaceutically acceptable salts, solvates, clathrates, stereoisomers, and prodrugs thereof. These compounds are suitable for treating, managing or preventing cancer, a disorder associated with angiogenesis, pain, macular degeneration or a related syndrome, a skin disease, a pulmonary disorder, an asbestos-related disorder, a parasitic disease, an immunodeficiency disorder, a CNS disorder, CNS injury, atherosclerosis or a related disorder, dysfunctional sleep or a related disorder, an infectious disease, hemoglobinopathy or a related disorder, or a TNFalpha related disorder.
Patent NZ-583635-A (NZ)
Title: Use of urate oxidase for the treatment or prophylaxis of disorders or indirect sequelae of the heart caused by ischemic or reperfusion events
Inventor: LINZ WOLFGANG
IPC: A61P9/10
Filed: 2008-08-20
Abstract: Disclosed is the use of Rasburicase for the treatment or prophylaxis of disorders or indirect sequelae of the heart caused by ischemic or reperfusion events.
Patent NZ-586032-A (NZ)
Title: An animal removal device as sensor and actuator to move attachment in rotary milking stall to make animal leave stall
Inventor: RETIKAUKAU JULIAN
IPC: A01J7/00
Filed: 2010-10-08
Abstract: For moving an animal out of a milking stall a stimulus device has an actuator, typically a pneumatic ram, that moves an attachment, typically padded and moved downwardly and outwardly. The actuator is actuated by a sensor that senses when the milking stall is in a predetermined position, typically when the stall is in position for the animal to exit after being milked.
Patent NZ-588119-A (NZ)
Title: Process for producing ultra-thin biscuits with a smooth surface
Inventor: BESSE NICOLAS
IPC: A23L7/109
Filed: 2008-06-25
Abstract: The disclosure relates to a process for making a thin biscuit having a smooth surface, comprising: - making a dough by mixing the ingredients at a temperature between 37°C and 70°C and more particularly between 40°C and 70°C to obtain a sheetable cohesive dough, said dough having the following composition in weight:. 0-56% of wheat flour. 4-62% of native starch. 1-26% of pre-gelatinised starch wherein for one unit of weight of native starch NS, pre-gelatinised starch PS, and wheat flour WF, i.e. with NS+PS+WF = 1 : WF ? 0.8, PS ? 0.37 and 0.7 ? NS/PS ? 9 and also comprising:. 5-18% of water, and preferably not higher than 16%. 2-12% of fat, and preferably not higher than 10%. 0-28% of sugar, with 0-8% of glucose syrup. 0-8% of whey powder and more particularly between 0 and 6%. 0%-0.5% of salt. 0-2% of other ingredients namely, flavour, colouring etc..., but devoid of a leavening agent; - sheeting the dough to a thickness between 0.2 and 1 mm; - cutting the sheeted dough into dough pieces, preferably individual dough pieces; - baking the dough pieces on a perforated support to obtain a thin biscuit that is devoid of blisters.
Patent NZ-590842-A (NZ)
Title: Dishwasher comprising a sorption drying unit
Inventor: DELLE DANIEL
IPC: A47L15/48
Filed: 2009-08-07
Abstract: Disclosed is a dishwasher which includes at least one washing container and at least one sorption drying system. The sorption drying system has a sorption container with reversibly dehydratable sorption material. The container is connected to the washing container by an air-guiding channel. The sorption container hangs beneath a base of the washing container at a predefined minimum distance away from neighbouring components of a base module to provide heat protection.
Patent NZ-592291-A (NZ)
Title: Platform for capturing wave energy
Inventor: MAYORAL GONZALEZ FELIX
IPC: F03B13/16
Filed: 2009-10-26
Abstract: 592291 A platform for capturing wave energy is disclosed. The platform includes a substantially delta, or v-shaped hull (2) adapted to be at least partially submersible and a series of pillars (3) mounted to the hull (2) forming passageways allowing flow of a wave between forward and aft portions of the platform. The pillars (3) provide a hydrodynamic profile in the direction of the oncoming wave. Wave energy capture modules (4) are located in the passageways (3) to absorb both kinematic and potential energy. A cover (1) is mounted over the pillars with a transmission means (15, 19) mounted on the cover. Energy absorbed by each module (4) is transferred to the transmission means for conversion by generators into usable energy including electrical energy.
Patent NZ-594810-A (NZ)
Title: Cellulases, nucleic acids encoding them and methods for making and using them
Inventor: BLUM DAVID
IPC: A62D3/00
Filed: 2006-01-13
Abstract: Provided is an isolated or recombinant nucleic acid comprising a nucleic acid sequence having at least 70% complete sequence identity to a specified sequence, wherein the nucleic acid encodes at least one polypeptide having a cellulase activity, or an enzymatically active fragment thereof. The nucleic acids and peptides can be used to produce transformed plants or to process cellulose to produce bread, beverages, paper and wood products and fuel.
Patent NZ-595872-A (NZ)
Title: A fastener abbembly with a collation strip collars which remain on the fastener shank even after being driven into a substrate.
Inventor: SUOPYS ALGIS P
IPC: F16B15/08
Filed: 2007-05-11
Abstract: 595872 A fastener assembly for use in an associated fastener driving tool for driving a fastener from the assembly into an associated substrate, the fastener assembly comprising: a row of fasteners arranged substantially parallel to each other and at an angle relative to an axis of a selected one of the fasteners, each fastener having a shank and a head, the head being larger in diameter than the shank, the shanks being spaced from adjacent shanks at least a distance so that the head of a fastener does not contact the shank of an adjacent fastener; and in a moulded tape-less collation system formed from a plastic material that is moulded onto and adhered to the fasteners, the plastic material defining a collar portion fully encircling the fastener shank, the plastic material further defining a connecting portion extending between and connecting adjacent collar portions, the connecting portion formed as a bridge and a rib, the plastic material being formulated from an adhesive polymer that is, at least in part, a modified polyolefin, the collar portion being formed on the shank a discrete length less than a length of the shank, wherein the collar portion and substantially the entire connecting portion remains adhered to the fastener at a location at which the collar portion is moulded onto the fastener shank even after being drive into a substrate.
Patent NZ-596807-A (NZ)
Title: Uses of immunoconjugates targeting cd138
Inventor: AIGNER SILKE
IPC: A61K47/48
Filed: 2010-05-05
Abstract: 596807 Disclosed is the use of an immunoconjugate in the manufacture of a medicament for treating a human patient with cancer having target cells expressing CD138: wherein the immunoconjugate comprises: at least one targeting antibody targeting CD138 expressing cells, and at least one effector molecule, wherein said targeting antibody is functionally attached to said effector molecule to form said immunoconjugate,wherein the medicament is adapted for administration of the immunoconjugate to the patient in an amount of the immunoconjugate from 5 mg/m2 to 200 mg/m2 or a pharmacokinetic equivalent of 5 mg/m2 to 200 mg/m2, wherein said amount is a tolerable amount, and wherein said targeting antibody: comprises residues 24-34 (CDR1), residues 50-56 (CDR2) and residues 89-97 (CDR3) of SEQ ID NO:2, and residues 31-35 (CDR1), residues 51-68 (CDR2) and residues 99-111 (CDR3) of SEQ ID NO:1, and wherein said immunoconjugate comprises a targeting antibody having a light chain having at least about 70% sequence identity with SEQ ID NO:2 and a heavy chain having at least about 70% sequence identity with SEQ ID NO:1; or has at least 90% sequence identity with nBT062 or corresponds to nBT062.
Patent NZ-599174-A (NZ)
Title: Combinations comprising a fungicidal strain and an azolopyrimidin-7-ylamine
Inventor: SCHOFL ULRICH
IPC: A01N63/02
Filed: 2008-09-16
Abstract: Disclosed is a fungicidal composition for controlling phytopathogenic harmful fungi, comprising 1) a fungicidal strain (I) selected from a) the Bacillus substilis strain with NRRL Accession No. B-21661, and b) the Bacillus pumilus strain with NRRL Accession No. B-30087, or a mutant of these strains having all the identifying characteristics of the respective strain, or a metabolite produced by the respective strain that exhibits activity against plant pathogenic fungi, and 2) at least one chemical compound (II), selected from a azolpyrimidin-7-ylamine as defined within the specification.
Patent NZ-600008-A (NZ)
Title: Multicyclic compounds and methods of use thereof
Inventor: HEWITT MICHAEL CHARLES
IPC: C07D495/20
Filed: 2010-12-03
Abstract: Disclosed are thieno[2,3-c]pyran derivatives represented by the structural formula depicted herein, and pharmaceutical uses thereof. These thieno[2,3-c]pyran derivatives are suitable for the treatment, prevention, or management of a neurological disorder selected from schizophrenia, schizophrenia spectrum disorder, acute schizophrenia, chronic schizophrenia, NOS schizophrenia, schizoid personality disorder, schizotypal personality disorder, delusional disorder, psychosis, psychotic disorder, brief psychotic disorder, shared psychotic disorder, psychotic disorder due to a general medical condition, drug-induced psychosis, psychoaffective disorder, aggression, delirium, Parkinson’s psychosis, excitative psychosis, Tourette’s syndrome, organic or NOS psychosis, seizure, agitation, post-traumatic stress disorder, behavior disorder, neurodegenerative disease, Alzheimer’s disease, Parkinson’s disease, dyskinesias, Huntington’s disease, dementia, mood disorder, anxiety, affective disorder, depression, major depressive disorder, dysthymia, bipolar disorder, manic disorder; seasonal affective disorder; attention deficit disorder, attention deficit hyperactivity disorder, obsessive-compulsive disorder, vertigo, epilepsy, pain, neuropathic pain, sensitization accompanying neuropathic pain, inflammatory pain, fibromyalgia, migraine, cognitive impairment, movement disorder, restless leg syndrome, multiple sclerosis, sleep disorder, sleep apnea, narcolepsy, excessive daytime sleepiness, jet lag, drowsy side effect of medications, insomnia, substance abuse or dependency, addiction, eating disorder, sexual dysfunction, hypertension, emesis, Lesche-Nyhane disease, Wilson’s disease, autism, Huntington’s chorea, and premenstrual dysphoria.
Patent NZ-600024-A (NZ)
Title: Spiroindolinone pyrrolidines
Inventor: ZHANG ZHUMING
IPC: A61K31/407
Filed: 2010-11-29
Abstract: Provided herein are compounds of the formula (I) or (II) wherein X, Y and R1 to R8 are described herein along with the enantiomers, pharmaceutically acceptable salts and esters thereof. The compounds are useful as antagonist of interactions between p53 and MDM2 which is useful in the treatment of cancer. In one embodiment the compound is (2’S,3’R,4’S,5’R)-6-chloro-4’-(3-chloro-2-fluoro-phenyl)-2’-(2,2-dimethyl-propyl)-2-oxo-1,2-dihydro-spiro[indole-3,3’-pyrrolidine]-5’-carboxylic acid [4-(2-hydroxy-ethoxy)-phenyl]-amide.
Patent NZ-602929-A (NZ)
Title: Improvements in and relating to the consideration of evidence
Inventor: PUCH-SOLIS ROBERTO
IPC: G16B40/00
Filed: 2011-03-10
Abstract: Disclosed is a computer-implemented method for considering DNA evidence. A computer compares a first and second sample result set obtained from donors, to automatically identify a match there between. The first sample result set includes the identities of alleles present at one or more loci in the DNA of a first sample, and the second sample result set includes the identities of alleles present at the same respective loci in the DNA of a second sample. The automatic identification of a match between the first and second sample result sets provides an indication of a potential match between at least one donor of the first sample and at least one donor of the second sample. Comparing the first and second sample result sets involves consideration of a likelihood ratio which provides an indication of the probability of the alleles being present at their respective loci in the DNA; the likelihood ratio is determined using a probability density function.
Patent NZ-605600-A (NZ)
Title: Unobtrusive interface systems
Inventor: RUMMERY GERARD MICHAEL
IPC: A61M16/06
Filed: 2009-03-04
Abstract: Disclosed is a patient interface suitable for delivering a flow of breathable gas to a patient. The patient interface has a generally cylindrical barrel with a first end and a second end. A pair of nasal prongs extend from the barrel between the first end and the second end. The nasal prongs are configured to engage the patient’s nares in a nonsealing manner to deliver the flow of breathable gas. The patient interface also has a tube connector connected to the generally cylindrical barrel and configured to connect the generally cylindrical barrel to a tube or cannula for delivering the flow of breathable gas. The tube connector has a first cylindrical portion configured to be connected to the barrel, a second cylindrical portion configured to be connected to the tube or cannula, and a third cylindrical portion connecting the first and second cylindrical portions. The interface further includes a a rigidized headgear attached to the first and second ends of the barrel.
Patent NZ-608168-A (NZ)
Title: Self-pressure-regulating compressed air engine comprising an integrated active chamber
Inventor: NEGRE GUY
IPC: F24S90/00
Filed: 2011-10-03
Abstract: A multimode engine comprising an included active chamber, having a cylinder (1) and a piston (2) that divides the cylinder into an active chamber (CA) and an expansion chamber (CD). In which compressed air contained in a tank (12) directly feeds the intake of the engine cylinder (1). The included active chamber (CA) is filled at a constant admission pressure at each engine revolution, the admission pressure decreasing as the pressure in the tank decreases. The volume of the included active chamber (CA) is increased, by allowing chamber filling for a longer portion of the piston stroke, progressively as the pressure in the tank (12) decreases. Intake valve actuating means enable not only the inlet opening and conduit (7) to be opened essentially at the top dead centre of the stroke of the piston, but also the modification of the duration and/or the angular sector of the admission. The volume of the included active chamber (CA) is dimensioned for maximum storage pressure, and is then progressively increased, resulting in a self-pressure regulating engine. Further, a means of preheating the intake gas is provided, either by solar or other means, to increase the work performed by the compressed gas.
Patent NZ-611410-A (NZ)
Title: Alkylsulfinyl-substituted thiazolide compounds
Inventor: SEMPLE J EDWARD
IPC: C07D495/04
Filed: 2011-10-27
Abstract: Disclosed are 2-hydroxy-N-(5-(methylsulfinyl)thiazol-2-yl)benzamide derivatives and analogues as represented by the general Formula (I), or a pharmaceutically acceptable salt thereof, for treating a subject exposed to a hepatitis C virus infection, wherein R1 is selected from the group consisting of hydrogen and Q-C(=O)-; R2 to R5 are hydrogen; wherein one of R6 or R7 is hydrogen, and the other is independently selected from the group consisting of alkylsulfinyl, alkylsulfinylalkyl, alkenylsulfinyl, alkynylsulfinyl, cycloalkylsulfinyl, cycloalkenylsulfinyl, arylsulfinyl, arylalkylsulfinyl, arylalkenylsulfinyl, heteroarylsulfinyl, heteroarylalkylsulfinyl, heteroarylalkenylsulfinyl, and heterocycloalkylsulfinyl; or the R6 and R7 moieties may be combined together with the atoms to which they are attached and joined to form a 5-to 8-membered ring that incorporates a sulfinyl moiety; and wherein Q is R8, OR8, NHR8, or NR8R9; R8 and R9 are independently selected from the group consisting of hydrogen, alkyl, alkenyl, alkynyl, cycloalkyl, aryl, arylalkyl, arylalkenyl, heterocycloalkyl, heteroaryl, heteroarylalkyl, and heteroarylalkenyl; or R8 and R9, together with the atoms to which they are attached, may be joined to form a 5-to 8-membered heterocycloalkyl ring. Representative compounds of formula (I) include 2-hydroxy-N-(5-(methylsulfinyl)thiazol-2-yl)benzamide, 2-{ [4-(methylsulfinyl)-1,3-thiazol-2-yl]carbamoyl} phenyl acetate, 2-hydroxy-N-[4-(methylsulfinyl)-1,3-thiazol-2-yl]benzamide, 2-hydroxy-N-[5-(ethylsulfinyl)-1,3-thiazol-2-yl]benzamide, 2-hydroxy-N-[5-(cyclohexylsulfinyl)-1,3-thiazol-2-yl]benzamide, 2-hydroxy-N-[5-(phenylsulfinyl)-1,3-thiazol-2-yl]benzamide, 2-hydroxy-N-[5-(benzylsulfinyl)-1,3-thiazol-2-yl]benzamide, isopropyl 2-{ [4-(pyrimidin-2-ylsulfinyl)-1,3-thiazol-2-yl]carbamoyl} phenyl carbonate, 2-{ [5-oxo-4,6-dihydro-thieno[3,4-d]thiazol-2-yl]carbamoyl} phenyl acetate and 2-hydroxy-N-(4-oxo-thieno[2,3-d][1,3]thiazol-2-yl)benzamide.
Patent NZ-612972-A (NZ)
Title: Masonry screws
Inventor: PAUL GAUDRON
IPC: F16B25/04
Filed: 2013-07-09
Abstract: A masonry screw has a shank (14) having a leading end (16), a trailing end (18) and a longitudinal axis (20) and a thread (22) winding around the shank. The thread has a leading flank (24) and a trailing flank (26). Between an adjacent leading flank (24) and trailing flank (26) the shank has a non-uniform diameter to define a depression (28) between those adjacent leading and trailing flanks. The depression has a first inclined face (42) that faces the trailing end (18).
Patent NZ-613925-A (NZ)
Title: Improved insecticide formulations
Inventor: WUJEK DENNIS G
IPC: A01P7/04
Filed: 2012-02-10
Abstract: Disclosed are insecticidal formulations comprising an insecticide such as chlorpyrifos-methyl which are microencapsulated in a polymer shell formed from isocyanate and a cross-linking amine such as ethylenediamine wherein the amine and isocyanate are present in a molar ratio of between about 0.5:1 and about 0.7:1. Also disclosed are methods of producing these formulations and their use in the control of insects.
Patent NZ-620213-A (NZ)
Title: Roof structure
Inventor: MARIO HURST
IPC: F16L59/12
Filed: 2014-01-21
Abstract: 620213 An insulated roof structure (20) is disclosed. The structure includes support members (21) with openings that accept bridge members (31) extending between them. End portions of the bridge members are able to be received by the openings in the support members such that the end portions can be inhibited from being withdrawn from the openings. A safety barrier (41) is supported by the bridge members and an insulating layer (42) including insulation pockets is supported by the safety barrier. This creates an air gap (60) between the insulation and the roof.
Patent NZ-626016-A (NZ)
Title: Smoking article with improved airflow
Inventor: MIRONOV OLEG
IPC: A24F42/60
Filed: 2013-02-12
Abstract: A smoking article (2) having a mouth end and a distal end, the smoking article (2) comprises: a heat source (4); an aerosol-forming substrate (6) downstream of the heat source (4); at least one air inlet downstream of the aerosol-forming substrate (6); and an airflow pathway (32) extending between the at least one air inlet and the mouth end of the smoking article (2). The airflow pathway (32) comprises a first portion extending longitudinally upstream from the at least one air inlet towards the aerosol-forming substrate (6) and a second portion extending longitudinally downstream from the first portion to the mouth end of the smoking article (2).
Patent NZ-626701-A (NZ)
Title: Device for rapid detection of infectious agents
Inventor: WILLIAMS MARVIN R
IPC: G01N33/50
Filed: 2012-12-12
Abstract: Disclosed is a system for rapidly detecting the presence of an infectious agent in a biological sample. The system comprises a single biosensor reagent including at least one antibody specific for a predetermined infectious agent and a bioluminescent agent, a single-use disposable test cartridge (300) and a testing unit (100) adapted to receive the single-use, disposable test cartridge (300). The single-use, disposable test cartridge (300) includes a reservoir card and a test cartridge base. The test cartridge base is configured to accept the reservoir card and wherein the test cartridge base further includes a single reaction chamber with the shape of a revolved half ellipse and an inlet channel connected to the reaction chamber, wherein the inlet channel is positioned above the reaction chamber at an angle of 15-60 degrees above the horizontal.
Patent NZ-627328-A (NZ)
Title: Closed fluid transfer system
Inventor: KOPLIN RANDALL SCOTT
IPC: A61J1/20
Filed: 2011-05-25
Abstract: A closed fluid transfer system for fluidly interconnecting a syringe to any one of a patient I.V. set, a vial and an I.V. bag, is provided and includes a first adapter defining a lumen and supporting a seal across a first end of its lumen, the first adapter supporting a rear end of a needle within the lumen, wherein the seal is movable relative to the needle such that a tip of the needle penetrates through the seal; and a second adapter defining a lumen and supporting a seal across a first end of its lumen; wherein when the second adapter is coupled to the first adapter, the second adapter seal abuts the first adapter seal and moves the first adapter seal relative to the tip of the needle such that the tip of the needle penetrates through the abutting first adapter seal and second adapter seal.
Patent NZ-709533-A (NZ)
Title: Spunbond nonwoven cloth
Inventor: JINNO FUMIO
IPC: D04H3/16
Filed: 2013-11-11
Abstract: [Problem] The present invention addresses the problem of providing a spunbond nonwoven cloth having excellent drape. [Solution] This spunbond nonwoven cloth is obtained by spinning and accumulating a thermoplastic resin into a continuous fiber, after which the spaces between the fibers are heated and compressed using an embossing roll provided with a plurality of embossments aligned in the flow direction of the fiber and the perpendicular direction thereof. Here, the embossing area ratio is 5-12%. Also, the minimum distance between adjacent embossments is 1.5-3 mm. Also, the bend stiffness index (bend stiffness [g/cm2/cm]/weight [g/m2] × 104 using a KES bend stiffness test machine) of the obtained nonwoven cloth is 5-15 cm-1. Also, the compression resilience (RC%) of the obtained nonwoven cloth using a KES compression characteristic test machine is 60-75%.
Patent NZ-712182-A (NZ)
Title: Nutritional composition comprising whey and hydrolyzed casein and uses thereof
Inventor: ALVEY JOHN
IPC: A23C21/08
Filed: 2014-04-15
Abstract: The present disclosure provides a nutritional composition, such as a preterm infant formula that includes a protein source comprising whey protein that is free of hydrolysed proteins and hydrolysed casein protein. The whey protein that is free of hydrolysed proteins is provided in a ratio to the hydrolysed casein from 90:10 to 50:50 by weight. The hydrolysed casein has a degree of hydrolysis of 30% to 70%. The formulation is provided for use in the promotion of gastric emptying and for the promotion of head growth and for improving the neurological outcome in a preterm infant.